RG 13022
CAS No. 136831-48-6
RG 13022 ( RG 13022;RG-13022.Tyrphostin RG 13022 )
Catalog No. M17260 CAS No. 136831-48-6
RG13022 is a tyrosine kinase inhibitor; inhibits the autophosphorylation reaction of the EGF receptor (IC50: 4 μM).
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 35 | In Stock |
|
5MG | 50 | In Stock |
|
10MG | 72 | In Stock |
|
25MG | 170 | In Stock |
|
50MG | 288 | In Stock |
|
100MG | 455 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRG 13022
-
NoteResearch use only, not for human use.
-
Brief DescriptionRG13022 is a tyrosine kinase inhibitor; inhibits the autophosphorylation reaction of the EGF receptor (IC50: 4 μM).
-
DescriptionRG-13022 is an inhibitor of epidermal growth factor (EGF) receptor kinase with an IC50 value of 1 μM in HT-22 cells. Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs.
-
SynonymsRG 13022;RG-13022.Tyrphostin RG 13022
-
PathwayOthers
-
TargetOther Targets
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number136831-48-6
-
Formula Weight266.29
-
Molecular FormulaC16H14N2O2
-
Purity98%
-
Solubility——
-
SMILESCOc1c(cc(cc1)/C=C(\C#N)/c1cnccc1)OC
-
Chemical Name3-Pyridineacetonitrile, alpha-((3,4-dimethoxyphenyl)methylene)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yoneda T,et al. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice. Cancer Res. 1991 Aug 15;51(16):4430-5.
molnova catalog
related products
-
Decyl-TPP bromide
Decyl-TPP bromide may be used as an intermediate for chemical synthesis and an inactive control or as a reference to mitoquinone (MitoQ).
-
Ciprofloxacin EP IMp...
Used as a new type of quinoline anti-bacterial drug ciprofloxacin intermediate.
-
2,2,14,14-Tetramethy...
2,2,14,14-Tetramethyl-8-oxopentadecanedioic acid is a ketone compound extracted from patent WO2002030860A2, compound example II-9. 2,2,14,14-Tetramethyl-8-oxopentadecanedioic acid can be used for the research of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders .